Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. - Wikidata - wikimedia - TriplyDB

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients.

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients.

http://www.wikidata.org/entity/Q37173563

about

New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease Challenges in Analyzing the Biological Effects of Resveratrol Experimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculature Resveratrol protects against methylglyoxal-induced hyperglycemia and pancreatic damage in vivo Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans.Adipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapy Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study.Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity.Resveratrol increases nitric oxide production in the rat thick ascending limb via Ca2+/calmodulin Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis.A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones.Resveratrol ameliorates the chemical and microbial induction of inflammation and insulin resistance in human placenta, adipose tissue and skeletal muscle The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial Supplementation of Coenzyme Q10 among Patients with Type 2 Diabetes Mellitus.Hepatic transcriptome implications for palm fruit juice deterrence of type 2 diabetes mellitus in young male Nile rats.Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility.Resveratrol supplementation: Where are we now and where should we go?Nutritional intervention and impact of polyphenol on glycohemoglobin (HbA1c) in non-diabetic and type 2 diabetic subjects: Systematic review and nmeta-analysis.Significance of Resveratrol in Clinical Management of Chronic Diseases.Antioxidant effects of resveratrol in the cardiovascular system.The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials.Functional foods and dietary supplements for the management of dyslipidaemia.Implications of Resveratrol on Glucose Uptake and Metabolism.Nrf2: a potential therapeutic target for diabetic neuropathy.Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action.Association Analysis of FOXO3 Longevity Variants With Blood Pressure and Essential Hypertension.The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus.Dietary (Poly)phenols, Brown Adipose Tissue Activation, and Energy Expenditure: A Narrative Review.Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis.Resveratrol attenuates visfatin and vaspin genes expression in adipose tissue of rats with type 2 diabetes Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.Effect of resveratrol and pterostilbene on aging and longevity.Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials.Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota.Resveratrol Improves Glycemic Control in Type 2 Diabetic Obese Mice by Regulating Glucose Transporter Expression in Skeletal Muscle and Liver.The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis.Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway.Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases.

P2860

Q26739475-973D9047-7E5C-4A17-AAF6-C234E7ADEA35 Q26746257-2CDA28A0-9793-4305-9DA1-FADACF8598D4 Q27016095-578DC3BA-FDC1-47B6-AF2D-7CDF5CC18BCF Q28393675-6442A315-5A43-4EC3-9F46-2CE6D38C45B2 Q29994589-17C2C5B2-E256-46CF-9A07-4CFAAA5157EA Q33701615-421B1A21-EC2A-43A9-B101-5E5391F2363E Q33791807-DE51329E-8845-469C-940A-5B8D00BC0F00 Q34112051-3CD5136E-42A0-494D-9A9F-AA8B08806F98 Q34312189-761B6537-3635-49C5-BECD-46DFE1CCC3D1 Q34338591-3C9DA46B-AEB6-4B99-8A2B-323A5275457D Q34434218-FA31ECB2-CEED-4E9C-8F5A-99E89DDD5B9C Q34570111-0A8DF345-6570-4C4E-AE12-009170CED545 Q36302354-C6F49ECE-282E-429C-9C6A-ABEF564A075E Q37035471-620A2685-7DB4-4E4C-AB71-22F24A66F932 Q37081597-10F24C85-7C04-4FEA-89A8-03369811A30E Q37358926-5F76930B-8A9E-49DF-9025-30EDD6B849CA Q37512665-0B7C5BFE-8449-4F60-8780-E8B4CF4CB6CB Q38334249-B1F417D2-1A4D-4F2F-9279-35819579B5F4 Q38369231-E6F5B175-5EDD-475A-8C65-55E4D9752BDC Q38618547-B77AB7E7-1FE3-4F40-B7D5-F4A9120C818F Q38802176-130C0609-AD0E-4CFE-B9F0-9BCCA8B4C930 Q38908273-82BDFB69-4F91-47EC-983F-2D48F4922636 Q39108473-B84278AF-8F6D-4E17-B443-BC8566C4E10F Q39168097-D5AFB88A-D86B-4F57-A255-BF46D29C35F9 Q39206295-ACFE8370-D8D2-4E50-A527-36ADFC923804 Q39432694-881E4456-0798-4850-BC28-0B5EDF6237B4 Q40421290-4956CF64-E522-41DD-8414-DC15A9AA3A70 Q41623135-2E211AAA-AB0E-4CA2-80EE-58FEB0025FE1 Q41997527-D240A931-9C7A-4EE2-AE7B-364C335C69D5 Q42172889-6EAFE645-DFA9-418D-8736-20C1970611E5 Q42368459-B661D224-ABC7-4B0B-A228-3F6F17C548E3 Q47192103-98505401-AABF-4F65-8659-1A98D9D40241 Q47279730-53155E18-8EF8-4510-B2F7-1207A548A0E2 Q47768938-8564B8F2-1256-49BE-B523-91AA2907A7F8 Q48048891-576FE328-28E3-4EBE-BCD6-96DD2F36EF94 Q50891043-F2273F86-46A3-4733-8E4B-FB7CDBD715DC Q51110611-FA1F3304-5D1F-407F-A13F-2E9CF30FD3D7 Q51300509-B51AA549-F1BB-4131-B3C5-081A02B351B4 Q54282810-E045CCD2-E596-4C14-BB77-45DA76000B2B Q55013574-47AE22A3-54E0-4E0B-BB4F-D5128FEE226C

P2860

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients.

http://www.wikidata.org/entity/Q37173563

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antihyperglycemic effects of s ...... n in type 2 diabetic patients.

@en

Antihyperglycemic effects of s ...... n in type 2 diabetic patients.

@nl

type

label

Antihyperglycemic effects of s ...... n in type 2 diabetic patients.

@en

Antihyperglycemic effects of s ...... n in type 2 diabetic patients.

@nl

prefLabel

Antihyperglycemic effects of s ...... n in type 2 diabetic patients.

@en

Antihyperglycemic effects of s ...... n in type 2 diabetic patients.

@nl

P1433

Q37173563-1431C280-FC86-46F5-A6CB-9493C36849C8

P1476

Q37173563-821B6CA6-BC0C-4F21-A143-4E3718EA9798

P2093

Q37173563-1EA50218-6D30-4882-9A28-8DB19F47580C

Q37173563-2EF10D80-F1C0-4987-B15C-766CEBACB4B9

Q37173563-45B8D73C-24DC-4D10-92EA-BDC642B604AF

Q37173563-59ED7BB3-5A48-4399-BB64-B2A04CB2FA95

Q37173563-898AC893-DFEA-4ADF-983A-50A02FDC11D0

Q37173563-9271EEC3-744C-47A9-93C7-5B467DD4E4F0

Q37173563-DB7D4906-F44C-4641-8DF3-DBE936BA25E1

Q37173563-E4A161D8-0FDD-4001-A2BA-973896549B9F

P2860

Q37173563-0C8C2E34-93B6-442A-9D5B-1FC7BECAA169

Q37173563-0FC16CA0-F702-4C29-8393-BD2FA24A133E

Q37173563-13900306-8D60-489C-A476-2C6276A63732

Q37173563-1C939C42-5449-40B3-813C-E64730EDD772

Q37173563-2654FB71-91EF-4819-A39E-7B3ABD02D282

Q37173563-2DC04D26-11A6-4442-BD35-E6C9A00069B5

Q37173563-34DEDCAE-1106-498B-A0C5-DD68C8CB0AB5

Q37173563-3C1BEBC2-2C07-420F-92B5-846ACD86C940

Q37173563-3E10708B-5E60-4BAB-9C92-21F48478EB10

Q37173563-4D4D7791-C348-4A0E-A0ED-01C06D1921A4

P304

Q37173563-E9610189-26C3-4E3E-8117-02645E24DE9B

P31

Q37173563-74CE8D34-99EA-456A-B1F8-DEC2841D7F51

P356

Q37173563-3CC49BF4-FA93-42EB-9F39-A33679F3EE21

P478

Q37173563-8A8F4F17-41AC-4748-8BD2-6D56884E53C0

P577

Q37173563-106BFBC3-62A3-4040-BC74-37976D04A55D

P5875

Q37173563-CF61FF36-582A-434E-B179-8405E541C1C6

P698

Q37173563-366196D9-F265-499E-B48F-BA2A7CF46559

P921

Q37173563-F660D846-29B3-4310-9D2F-B870F7EC0DE8

P932

Q37173563-5435E932-ADD2-4120-8302-4BAFAB561D12

P356

P1433

Evidence-based Complementary and Alternative Medicine

P1476

Antihyperglycemic effects of s ...... n in type 2 diabetic patients.

@en

P2093

Ali Movahed

http://www.w3.org/2001/XMLSchema#string

Iraj Nabipour

http://www.w3.org/2001/XMLSchema#string

Liping Yu

http://www.w3.org/2001/XMLSchema#string

Mohammadreza Kalantarhormozi

http://www.w3.org/2001/XMLSchema#string

Seyed Javad Rekabpour

http://www.w3.org/2001/XMLSchema#string

Sijo Joseph Thandapilly

http://www.w3.org/2001/XMLSchema#string

Thomas Netticadan

http://www.w3.org/2001/XMLSchema#string

Xavier Lieben Louis

http://www.w3.org/2001/XMLSchema#string

P2860

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Cellular and molecular effects of resveratrol in health and disease

Use and abuse of HOMA modeling

Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control

Evaluation of methods for the measurement of low-density lipoprotein cholesterol.

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

Current views on type 2 diabetes.

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

P304

851267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/851267

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257136431

http://www.w3.org/2001/XMLSchema#string

P698

24073011

http://www.w3.org/2001/XMLSchema#string

P921

P932

3773903

http://www.w3.org/2001/XMLSchema#string